CIK 0001650648 · Non-accelerated filer<br>Smaller reporting company
4D Molecular Therapeutics, Inc.
Sign in to watch- Ticker
- FDMT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473506994
- Phone
- 5105052680
- Business address
- 5858 HORTON STREET #455, EMERYVILLE, CA, 94608
- Former names
- 4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,724,648
- in 7 filings, $2.7M under 10b5-1 plans
Net −$2,724,648. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-12 | Moretti August J Chief Financial Officer | Option exercise | +1,000 | $9.41 | $9K | 2,000 |
| 2021-04-12 | Moretti August J Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −1,000 | 223,060 | ||
| 2021-03-08 | Kamal Fariborz See Remarks | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2021-03-08 | Kirn David See Remarks | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2021-03-08 | Moretti August J See Remarks | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2020-12-15 | MILLIGAN JOHN F Director | Purchase | +100,000 | $23.00 | $2.3M | 100,000 |
| 2020-12-15 | Kamal Fariborz See Remarks | Purchase | +4,347 | $23.00 | $100K | 4,347 |
| 2020-12-15 | YAO TONY DUNG LING Director | Conversion | +2,864 | 2,864 | ||
| 2020-12-15 | YAO TONY DUNG LING Director | Conversion | +455,326 | 455,326 | ||
| 2020-12-15 | YAO TONY DUNG LING Director | Conversion | +180,554 | 635,880 | ||
| 2020-12-15 | YAO TONY DUNG LING Director | Purchase | +425,000 | $23.00 | $9.8M | 1,060,880 |
| 2020-12-15 | YAO TONY DUNG LING Director | Conversion · Series B Preferred Stock | −2,864 | 0 | ||
| 2020-12-15 | YAO TONY DUNG LING Director | Conversion · Series B Preferred Stock | −455,326 | 0 | ||
| 2020-12-15 | YAO TONY DUNG LING Director | Conversion · Series C Preferred Stock | −180,554 | 0 | ||
| 2020-12-15 | VIKING GLOBAL INVESTORS LP 10% owner | Conversion | +2,004,581 | 2,004,581 | ||
| 2020-12-15 | VIKING GLOBAL INVESTORS LP 10% owner | Conversion | +833,333 | 2,837,914 | ||
| 2020-12-15 | VIKING GLOBAL INVESTORS LP 10% owner | Purchase | +1,100,000 | $23.00 | $25.3M | 3,937,914 |
| 2020-12-15 | VIKING GLOBAL INVESTORS LP 10% owner | Conversion · Series B Redeemable Convertible Preferred Stock | −2,004,581 | 0 | ||
| 2020-12-15 | VIKING GLOBAL INVESTORS LP 10% owner | Conversion · Series C Redeemable Convertible Preferred Stock | −833,333 | 0 |
Page 16 of 16 · 319 trades